Eloxx Pharmaceuticals, Inc.
ELOX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $19 | $42 | $25 | $22 |
| Short-Term Investments | $0 | $0 | $0 | $34 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $1 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $20 | $43 | $26 | $58 |
| Property Plant & Equip (Net) | $1 | $2 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $2 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $21 | $45 | $26 | $59 |
| Liabilities | – | – | – | – |
| Payables | $3 | $1 | $0 | $2 |
| Short-Term Debt | $5 | $1 | $6 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $13 | $4 | $1 | $0 |
| Other Curr. Liab. | $3 | $4 | $3 | $5 |
| Total Curr. Liab. | $23 | $10 | $10 | $12 |
| LT Debt | $9 | $13 | $6 | $11 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $9 | $13 | $6 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $0 | $1 |
| Total Liabilities | $32 | $23 | $16 | $23 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$274 | -$238 | -$172 | -$137 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $264 | $261 | $181 | $173 |
| Total Equity | -$11 | $22 | $10 | $36 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $21 | $45 | $26 | $59 |
| Net Debt | -$6 | -$29 | -$13 | -$7 |